MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3389/fcimb.2025.1584261

Медицинская библиотека · Frontiers in cellular and infection microbiology · 2025

Effectiveness and safety of azvudine in the treatment of COVID-19 patients: a retrospective cohort study using propensity score matching.

Zhang Jing, Wang Fang, Xie Ying, Li Qianyu, Zhu Zhenzhen, Dong Yuan

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Clinical trials have demonstrated the efficacy of azvudine in alleviating clinical symptoms among patients with coronavirus disease 2019 (COVID-19). However, evidence regarding its real-world effectiveness and safety profile remains limited.

OBJECTIVE

To evaluate the effectiveness and safety of azvudine in COVID-19 patients.

METHODS

This retrospective cohort study included 192 COVID-19 patients hospitalized in Fengtai District, Beijing, from November 1 to December 31, 2022. Patients were divided into azvudine (n=118) and non-azvudine (n=74) groups. Propensity score matching (PSM) was applied to balance baseline characteristics (age, sex, vaccination status, etc.), yielding 48 matched pairs. Outcomes included time to SARS-CoV-2 RNA negativity, hospitalization duration, and symptom resolution (fever, cough). Adverse events were recorded.

RESULTS

After PSM, 48 pairs of COVID-19 patients were identified. The azvudine group exhibited significantly shorter hospitalization than the non-azvudine group (median: 8 vs. 10 days, P ≤ 0.05). No significant differences were observed in time to RNA negativity (4.23 vs. 4.52 days, P>0.05), fever duration (2 vs. 2 days, P>0.05), or cough duration (4.5 vs. 5 days, P>0.05). One case of mild gastrointestinal discomfort was reported in the azvudine group.

CONCLUSION

Azvudine significantly reduced hospitalization duration in mild-to-moderate COVID-19 patients with a favorable safety profile.

Для цитирования: Zhang Jing, Wang Fang, Xie Ying, Li Qianyu, Zhu Zhenzhen, Dong Yuan. Effectiveness and safety of azvudine in the treatment of COVID-19 patients: a retrospective cohort study using propensity score matching.. Frontiers in cellular and infection microbiology. 2025. DOI: 10.3389/fcimb.2025.1584261.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.